• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[115例高催乳素血症患者中巨催乳素血症的患病率]

[Prevalence of macroprolactinemia among 115 patients with hyperprolactinemia].

作者信息

Vilar Lucio, Moura Eliane, Canadas Viviane, Gusmão Amaro, Campos Renata, Leal Edmundo, Teixeira Luciano, Santos Vera, Gomes Barbara, Lima Marise, Paiva Renata, Albuquerque José Luciano, Egito Célia S, Botelho Carlos A, Azevedo Monalisa, Casulari Luiz Augusto, Naves Luciana A

机构信息

Serviço de Endocrinologia, Hospital das Clínicas, Universidade Federal de Pernambuco.

出版信息

Arq Bras Endocrinol Metabol. 2007 Feb;51(1):86-91. doi: 10.1590/s0004-27302007000100014.

DOI:10.1590/s0004-27302007000100014
PMID:17435860
Abstract

Macroprolactinemia is characterized by the predominance in the serum of macroprolactin, a prolactin (PRL) with high molecular mass and low biological activity that does not need treatment. The prevalence of macroprolactinemia was evaluated in 115 consecutive patients with hyperprolactinemia. Among them, 19 (16.5%) had solely macroprolactinemia, 4 (3.5%) polycystic ovary syndrome, 7 (6.1%) acromegaly, 8 (6.9%) idiopathic hyperprolactinemia, 10 (8.6%) primary hypothyroidism, 14 (12.2%) clinically non-functioning pituitary adenomas, 20 (17.4%) drug-induced hyperprolactinemia and 33 (28.7%) prolactinomas. The diagnosis of macroprolactinemia was established by the demonstration of a PRL recovery < 30% after treatment of sera with polyethylene glycol. Among the 19 patients with isolated macroprolactinemia, 16 (84.2%) were female and 12 (63.2%) were asymptomatic, while 4 (21%) presented with oligomenorrhea and 3 (15.8%) with galactorrhea. In contrast, only 11.5% of individuals with other causes of hyperprolactinemia were asymptomatic (p< 0.001). Prolactin levels in cases of macroprolactin ranged from 45.1 to 404 ng/mL (mean 113.3 +/- 94.5) but in 15 (78.9%) were < 100 ng/mL. Our findings demonstrate that macroprolactinemia is a common condition and, therefore, we suggest that it should be routinely screened in patients with hyperprolactinemia.

摘要

巨泌乳素血症的特征是血清中以巨泌乳素为主,巨泌乳素是一种高分子量、低生物活性的泌乳素(PRL),无需治疗。对115例连续的高泌乳素血症患者评估了巨泌乳素血症的患病率。其中,19例(16.5%)仅患有巨泌乳素血症,4例(3.5%)患有多囊卵巢综合征,7例(6.1%)患有肢端肥大症,8例(6.9%)患有特发性高泌乳素血症,10例(8.6%)患有原发性甲状腺功能减退症,14例(12.2%)患有临床无功能垂体腺瘤,20例(17.4%)患有药物性高泌乳素血症,33例(28.7%)患有泌乳素瘤。通过用聚乙二醇处理血清后PRL回收率<30%来确立巨泌乳素血症的诊断。在19例孤立性巨泌乳素血症患者中,16例(84.2%)为女性,12例(63.2%)无症状,4例(21%)表现为月经过少,3例(15.8%)表现为溢乳。相比之下,其他原因导致的高泌乳素血症患者中只有11.5%无症状(p<0.001)。巨泌乳素血症患者的泌乳素水平范围为45.1至404 ng/mL(平均113.3±94.5),但15例(78.9%)<100 ng/mL。我们的研究结果表明,巨泌乳素血症是一种常见病症,因此,我们建议对高泌乳素血症患者应常规筛查该病。

相似文献

1
[Prevalence of macroprolactinemia among 115 patients with hyperprolactinemia].[115例高催乳素血症患者中巨催乳素血症的患病率]
Arq Bras Endocrinol Metabol. 2007 Feb;51(1):86-91. doi: 10.1590/s0004-27302007000100014.
2
Importance of macroprolactinemia in hyperprolactinemia.巨泌乳素血症在高泌乳素血症中的重要性。
Eur J Obstet Gynecol Reprod Biol. 2014 Dec;183:28-32. doi: 10.1016/j.ejogrb.2014.10.013. Epub 2014 Oct 20.
3
[Macroprolactinemia in the differential diagnosis of hyperprolactinemia].[高催乳素血症鉴别诊断中的巨催乳素血症]
Orv Hetil. 2003 Oct 26;144(43):2121-7.
4
Prevalence and reproductive manifestations of macroprolactinemia.巨泌乳素血症的流行情况和生殖表现。
Endocrine. 2019 Feb;63(2):332-340. doi: 10.1007/s12020-018-1770-6. Epub 2018 Sep 29.
5
Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center.高催乳素血症患者中的巨泌乳素血症:来自单一三级中心的经验
Pan Afr Med J. 2020 May 6;36:8. doi: 10.11604/pamj.2020.36.8.22923. eCollection 2020.
6
Frequency of Macroprolactin in Hyperprolactinemia.高泌乳素血症中大分子泌乳素的发生率。
J Coll Physicians Surg Pak. 2018 Feb;28(2):93-97. doi: 10.29271/jcpsp.2018.02.93.
7
Macroprolactinemia: the consequences of a laboratory pitfall.巨泌乳素血症:实验室检测失误的后果
Endocrine. 2003 Dec;22(3):267-73. doi: 10.1385/ENDO:22:3:267.
8
Prevalence of Macroprolactinemia in People Detected to Have Hyperprolactinemia.检测出高催乳素血症的人群中巨催乳素血症的患病率。
J Lab Physicians. 2021 Jul 12;13(4):353-357. doi: 10.1055/s-0041-1732490. eCollection 2021 Dec.
9
Macroprolactinemia: diagnostic, clinical, and pathogenic significance.巨泌乳素血症:诊断、临床及致病意义
Clin Dev Immunol. 2012;2012:167132. doi: 10.1155/2012/167132. Epub 2012 Dec 4.
10
Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia.高催乳素血症女性中巨泌乳素血症的实验室及临床意义
Taiwan J Obstet Gynecol. 2017 Dec;56(6):719-724. doi: 10.1016/j.tjog.2017.10.002.

引用本文的文献

1
The frequency of macroprolactinemia among patients with hyperprolactinemia in a central laboratory of a training and research hospital.一家培训和研究医院中心实验室中高催乳素血症患者的巨催乳素血症发生率。
North Clin Istanb. 2024 Nov 21;11(6):520-524. doi: 10.14744/nci.2023.94758. eCollection 2024.
2
Prevalence and reproductive manifestations of macroprolactinemia.巨泌乳素血症的流行情况和生殖表现。
Endocrine. 2019 Feb;63(2):332-340. doi: 10.1007/s12020-018-1770-6. Epub 2018 Sep 29.
3
Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.
高催乳素血症和催乳素瘤管理中的争议问题——巴西内分泌与代谢学会神经内分泌学部门概述
Arch Endocrinol Metab. 2018 Mar-Apr;62(2):236-263. doi: 10.20945/2359-3997000000032.
4
Management of prolactinomas in Brazil: an electronic survey.巴西泌乳素瘤的管理:一项电子调查。
Pituitary. 2010 Sep;13(3):199-206. doi: 10.1007/s11102-010-0217-8.
5
Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients.高泌乳素血症的诊断与管理:一项针对1234例患者的巴西多中心研究结果
J Endocrinol Invest. 2008 May;31(5):436-44. doi: 10.1007/BF03346388.